Brief: Clovis Oncology Announces Preliminary Product Revenues For Q4 And Full Year 2020
11/01/2021 13:22
Jan 11 (Reuters) - Clovis Oncology Inc CLVS.O :
* CLOVIS ONCOLOGY ANNOUNCES PRELIMINARY PRODUCT REVENUES FOR
THE
FOURTH QUARTER AND FULL YEAR 2020
* CLOVIS ONCOLOGY INC - $43.0M - $43.5M IN ESTIMATED RUBRACA
GLOBAL PRODUCT REVENUES FOR Q4 OF 2020
* CLOVIS ONCOLOGY INC - $164.2M -$164.7M IN ESTIMATED
RUBRACA
PRODUCT REVENUES FOR FY 2020
Source text for Eikon: ID:nBw4GpyFfa
Further company coverage: CLVS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clovis Oncology
See all newsBrief: Clovis Oncology Inc - On April 5, 2023, Entered Into Asset Purchase Agreement With Pharma& To Sell Product Business For Upfront Payment Of $70 Million
Brief: Clovis Oncology Enters Into Financing Agreement
Brief: Clovis Oncology Inc Received Written Notice From Nasdaq That Company's Common Stock Will Be Delisted From Nasdaq
U.S. STOCKS ON THE MOVE-Nike, Faraday Future, PBF Energy
U.S. STOCKS ON THE MOVE-Natural gas, Box Inc, Weber